← Leaderboards
Juan Pablo Cata
Altality, Inc.
$627,746
Attributed
$2,418,069
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,418,069 · 2
By mechanism
R42$2,107,073 · 1
R43$310,996 · 1
Top collaborators
- Christina York5 shared
- Jae Eun Choi4 shared
- Clinton Fuller2 shared
- Christopher Monteferrante2 shared
- Jamie W Sinton1 shared
Most similar at Altality, Inc.
Same institution · by research overlap
- Christina York$627,746
- Clinton Fuller$457,082
- Christopher Monteferrante$77,749
- Jamie W Sinton$514,050
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsPainHigh RiskMalignant Childhood NeoplasmOperative Surgical ProceduresOpioid UseDiagnosisDependenceFutureInpatientsChronicHospitalsAugmented RealityOpiate AddictionAdultCostCancer CenterCancer PatientCaregiversCollaborationsFamilyChildChildhoodPain Management
Grant awards (5)
Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients$55,000
R43 · FY2023 · DA
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer$912,905
R42 · FY2022 · DA
Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients$255,996
R43 · FY2022 · DA
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer$915,421
R42 · FY2021 · DA
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer$278,747
R42 · FY2020 · DA